118 related articles for article (PubMed ID: 11245850)
1. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries.
Edvinsson L; Sams A; Jansen-Olesen I; Tajti J; Kane SA; Rutledge RZ; Koblan KS; Hill RG; Longmore J
Eur J Pharmacol; 2001 Mar; 415(1):39-44. PubMed ID: 11245850
[TBL] [Abstract][Full Text] [Related]
2. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
4. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
[TBL] [Abstract][Full Text] [Related]
5. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
Schindler M; Doods HN
Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
[TBL] [Abstract][Full Text] [Related]
6. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries.
Ohlsson L; Haanes KA; Kronvall E; Xu C; Snellman J; Edvinsson L
Cephalalgia; 2019 Dec; 39(14):1745-1752. PubMed ID: 31366221
[TBL] [Abstract][Full Text] [Related]
7. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects.
Edvinsson L; Ekman R; Jansen I; McCulloch J; Uddman R
J Cereb Blood Flow Metab; 1987 Dec; 7(6):720-8. PubMed ID: 3500957
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase.
Jansen-Olesen I; Mortensen A; Edvinsson L
Cephalalgia; 1996 Aug; 16(5):310-6. PubMed ID: 8869765
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries.
Rubio-Beltran E; Chan KY; Danser AJ; MaassenVanDenBrink A; Edvinsson L
Cephalalgia; 2020 Apr; 40(4):357-366. PubMed ID: 31674221
[TBL] [Abstract][Full Text] [Related]
11. In-depth characterization of CGRP receptors in human intracranial arteries.
Jansen-Olesen I; Jørgensen L; Engel U; Edvinsson L
Eur J Pharmacol; 2003 Nov; 481(2-3):207-16. PubMed ID: 14642788
[TBL] [Abstract][Full Text] [Related]
12. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide (CGRP) regulates excitability and refractory period of the guinea pig ureter.
Maggi CA; Giuliani S
J Urol; 1994 Aug; 152(2 Pt 1):520-4. PubMed ID: 8015106
[TBL] [Abstract][Full Text] [Related]
14. Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries.
Sheykhzade M; Lind H; Edvinsson L
Br J Pharmacol; 2004 Dec; 143(8):1066-73. PubMed ID: 15477223
[TBL] [Abstract][Full Text] [Related]
15. Neurogenic vasodilation in rabbit basilar isolated artery: involvement of calcitonin-gene related peptide.
Olivar T; Razzaque Z; Nwagwu M; Longmore J
Eur J Pharmacol; 2000 Apr; 395(1):61-8. PubMed ID: 10781675
[TBL] [Abstract][Full Text] [Related]
16. Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries.
Ohlsson L; Kronvall E; Stratton J; Edvinsson L
J Headache Pain; 2018 Aug; 19(1):66. PubMed ID: 30109438
[TBL] [Abstract][Full Text] [Related]
17. Characterization of calcitonin gene-related peptide (CGRP) receptors in guinea pig basilar artery.
Jansen I
Neuropeptides; 1992 Feb; 21(2):73-9. PubMed ID: 1313553
[TBL] [Abstract][Full Text] [Related]
18. Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP.
Edvinsson L; Jansen Olesen I; Kingman TA; McCulloch J; Uddman R
Cephalalgia; 1995 Oct; 15(5):373-83. PubMed ID: 8536296
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CGRP(1) receptors in the guinea pig basilar artery.
Jansen-Olesen I; Kaarill L; Edvinsson L
Eur J Pharmacol; 2001 Mar; 414(2-3):249-58. PubMed ID: 11239926
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells.
Van Valen F; Piechot G; Jürgens H
Neurosci Lett; 1990 Nov; 119(2):195-8. PubMed ID: 2177866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
